New York City has a goal to become one of the premier biotech hubs in the US – on par with innovation centers like Cambridge, MA, and San Francisco. The city launched LifeSci NYC in 2016 with a $1bn public investment to create new jobs, foster talent and establish lab and incubator space, and it has made progress toward its goal of cultivating 1,000 R&D-stage companies and 40,000 new jobs in the city.
NYC’s Ambition: Be A Premier Biotech Hub
New York has its eye on becoming a premier biotech hub and is investing heavily in life sciences. Experts weighed in on the positives and drawbacks of the city for biotechs at a new innovation campus called Cure.
